缔脉生物医药科技（上海）有限公司 DMED BIOPHARMACEUTICAL CO. LTD.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
dMed-Clinipace Announces Completion of US$50 Million Series C+ Financing from New Investors 2021-07-07 20:00
Recently Merged dMed and Clinipace Announce the Appointment of New Global COO 2021-05-21 20:00
CROs dMed and Clinipace Merge to Accelerate Customer Success 2021-04-28 20:00
dMed Completed a US$100 Million Series C Financing 2020-12-17 13:00
dMed raises nearly US$50 million in Series B financing to strengthen and expand its clinical operations capability and global infrastructure 2019-10-16 15:15
Target Health and dMed Biopharmaceuticals Join Forces to Help Western and Chinese Biopharma and Device Companies 2019-06-25 04:00
dMed Biopharmaceutical, a next generation CRO, announced the opening of its US Regulatory Affairs office in Washington DC to build a bridge for affordable innovative drugs for US patients 2019-06-19 23:59
1